Your browser doesn't support javascript.
loading
Diversity of intratumoral regulatory T cells in B-cell non-Hodgkin lymphoma.
Spasevska, Ivana; Sharma, Ankush; Steen, Chloé B; Josefsson, Sarah E; Blaker, Yngvild N; Kolstad, Arne; Rustad, Even H; Meyer, Saskia; Isaksen, Kathrine; Chellappa, Stalin; Kushekhar, Kushi; Beiske, Klaus; Førsund, Mette S; Spetalen, Signe; Holte, Harald; Østenstad, Bjørn; Brodtkorb, Marianne; Kimby, Eva; Olweus, Johanna; Taskén, Kjetil; Newman, Aaron M; Lorenz, Susanne; Smeland, Erlend B; Alizadeh, Ash A; Huse, Kanutte; Myklebust, June H.
Afiliación
  • Spasevska I; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Sharma A; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.
  • Steen CB; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
  • Josefsson SE; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Blaker YN; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.
  • Kolstad A; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
  • Rustad EH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Meyer S; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.
  • Isaksen K; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
  • Chellappa S; Division of Oncology, Stanford University School of Medicine, Stanford, CA.
  • Kushekhar K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Beiske K; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.
  • Førsund MS; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Spetalen S; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.
  • Holte H; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.
  • Østenstad B; Department of Oncology, Innlandet Hospital Trust, Lillehammer, Norway.
  • Brodtkorb M; Division of Cancer Medicine, Department of Oncology, Oslo University Hospital, Oslo, Norway.
  • Kimby E; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Olweus J; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
  • Taskén K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Newman AM; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
  • Lorenz S; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Smeland EB; KG Jebsen Centre for B-cell malignancies, Institute of Clinical Medicine, University of Oslo, Norway.
  • Alizadeh AA; Precision Immunotherapy Alliance, University of Oslo, Oslo, Norway.
  • Huse K; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
  • Myklebust JH; Department of Cancer Immunology, Institute for Cancer Research, Oslo University Hospital, Oslo, Norway.
Blood Adv ; 7(23): 7216-7230, 2023 12 12.
Article en En | MEDLINE | ID: mdl-37695745
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma Folicular / Linfoma de Células B Grandes Difuso Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Noruega
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfoma Folicular / Linfoma de Células B Grandes Difuso Límite: Humans Idioma: En Revista: Blood Adv Año: 2023 Tipo del documento: Article País de afiliación: Noruega